RDWM
IBB icon

Red Door Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

Red Door Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$320K Buy
1,682
+17
+1% +$2.92K 0.03% 244
2026
Q1 		$281K Buy
1,665
+1
+0.1% +$171 0.03% 239
2025
Q4 		$281K Buy
1,664
+2
+0.1% +$325 0.03% 237
2025
Q3 		$240K Sell
1,662
-101
-6% -$13.8K 0.03% 256
2025
Q2 		$223K Buy
+1,763
New +$216K 0.03% 247
2022
Q1 		– Sell
-1,491
Closed -$227K – 149
2021
Q4 		$227K Hold
1,491
– – 0.07% 148
2021
Q3 		$241K Buy
1,491
+47
+3% +$7.91K 0.09% 145
2021
Q2 		$236K Buy
+1,444
New +$222K 0.09% 139

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Red Door Wealth Management's IBB Position: Q2 2026 in Review

Red Door Wealth Management increased its iShares Biotechnology ETF (IBB) stake by 1% in Q2 2026, buying an estimated $2.92K and bringing the position to 1,682 shares worth $320K. The position accounts for 0.03% of the portfolio, ranked #244.

Red Door Wealth Management first reported a position in IBB in Q2 2021 and has held it in 8 quarters since. 486 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Red Door Wealth Management held 1,682 shares of iShares Biotechnology ETF worth $320K as of Q2 2026.
  • Red Door Wealth Management bought 17 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.92K.
  • iShares Biotechnology ETF made up 0.03% of Red Door Wealth Management's portfolio in Q2 2026, its #244 holding.
  • Red Door Wealth Management first reported a position in iShares Biotechnology ETF in Q2 2021 and has held it in 8 quarters since.
  • 486 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.